Status:
NOT_YET_RECRUITING
Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Myoma
Surgery
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at tim...
Detailed Description
Background: Leiomyomas are the most common benign tumor of the uterus and affect approximately 70-80% of the population with a uterus . Patients who opt to undergo treatment for a fibroid uterus have ...
Eligibility Criteria
Inclusion
- Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
- Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids
Exclusion
- Pregnancy,
- Age \<18yo,
- Patients undergoing concomitant surgery such as endometriosis surgery,
- Suspected malignancy
Key Trial Info
Start Date :
September 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2029
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07182045
Start Date
September 18 2025
End Date
September 30 2029
Last Update
September 23 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.